Scientific Director, Medical Affairs

Verastem Oncology
Boston, MA
F

Director, Medical Affairs (Epilepsy)

Xenon Pharmaceuticals Inc.
Boston, MA
F

Senior Director, Medical Affairs

Formation Bio
Boston, MA
F

Director, Medical Affairs Operations

Egetis Therapeutics
Greater Boston
F

Senior Director, Medical Affairs

Tango Therapeutics
Boston, MA
F

Project Management, Associate Director (Medical Affairs)

Vertex Pharmaceuticals
Boston, MA
F

Head of Medical Information (Director/Senior Director) – Medical Affairs

Vor Bio
Boston, MA
F

Senior Director, Global Medical Affairs - Nephrology

Vertex Pharmaceuticals
Boston, MA
F

Senior Director, US Medical Affairs – Nephrology

Vertex Pharmaceuticals
Boston, MA
F

Medical Director, Global Medical Affairs - Lung Cancer

BioSpace
Boston, MA
F

Medical Director, Global Medical Affairs - Lung Cancer

BioSpace
Boston, MA
F

Medical Director, Global Medical Affairs - Lung Cancer

Takeda
Boston, MA
F

Senior Medical Director - US Medical Affairs - Nephrology

Vertex Pharmaceuticals
Boston, MA
F

Medical Director, Global Medical Affairs - Gastric/Pancreatic Cancer

BioSpace
Boston, MA
F

Medical Affairs Medical Director, Hematology (US Medical Affairs)

Vertex Pharmaceuticals
Boston, MA
F
Verastem Oncology company logo

Scientific Director, Medical Affairs

Verastem Oncology

Boston, MA

Full-time

Others

Company Profile:

At Verastem Oncology, we're advancing innovation and addressing the urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. The FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy specifically for women living with recurrent KRAS-mutated low-grade serous ovarian cancer, a rare cancer with significant unmet need. We’ve successfully launched this innovative combination therapy in the U.S. and are exploring regulatory pathways for Europe and Japan. We are continuing to advance our pipeline of drugs that we believe will help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. With clinical trials underway, we have an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients



Responsibilities:

  • Lead/co-lead the strategic publication plan across indications for VS-7375, aligned with the Clinical Development and Medical Affairs strategy and objectives
  • Interact and lead discussions with external authors and internal collaborators to develop publication content related to ongoing and planned studies.
  • Write and edit publications as needed including manuscripts, congress abstracts, slide presentations, and posters. Manage external agencies and freelancers
  • Lead/Contribute to the development of scientific platforms
  • Drive a cohesive advisory committee and advisory board plan, working closely with Medical Affairs leadership and cross-functional partners in Clinical Development and Executive Leadership
  • Develop content (including oversight of vendors) to support Advisory Committees / Advisory Boards; work with Medical Affairs Operations to ensure smooth execution of these events
  • Assist in the development of training materials / resources (eg, slide decks) to support scientific exchange
  • Support congress coverage / CI activities (planning and reports covering key sessions at major meetings).Review proposals for independent research (eg, ISTs) and lead independent research review meetings with cross-functional medical and scientific leads
  • Work with corporate communications / investor relations and other internal teams to ensure the scientific accuracy of external messages
  • Ensure that activities are within company policies, procedures and good publications practices


Qualifications:

  • Degree in a scientific discipline. Advanced degree is preferred (MS, MPH, PharmD. or PhD)
  • Minimum 8 years of experience in the pharmaceutical industry (eg, Clinical Development, Medical Writing, or Medical Affairs), a consulting organization, or medical communications company. Medical Affairs / Medical Communications experience preferred.
  • Experience in oncology
  • Ability to critically appraise and apply knowledge gained from the medical/scientific literature
  • Ability to communicate in a clear and targeted way to different audiences including senior and executive team leadership
  • Ability to effectively communicate complex medical/scientific information to external audiences
  • Comfortable working in a fast-paced environment with a flexible mindset
  • Understand the clinical development process, especially clinical study data and outcomes measures in oncology
  • Familiar with publication guidelines and good publication practices (eg, GPP, ICMJE)
  • Strong interpersonal skills for effective professional communications, aiming to cultivate strong working relationships with both internal and external groups
  • Ability to travel up to 20% of the time


The base salary range ($200K-$250K) provided reflects our current estimate of what we anticipate paying for this position. Your actual base salary will be based on several factors, including job-related skills, experience, internal equity, relevant education or training, location, and market dynamics. In addition, you will be eligible for an annual bonus, equity compensation, and a competitive benefits package.

About the company

Company websiteBiotechnology Research

Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition and KRAS G12D inhibition.

Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by delivering novel therapies that address areas of high unmet need in RAS/MAPK pathway-driven cancers. At Verastem Oncology, it takes our diversity of backgrounds, expertise, perspectives, and skills to find the answers that patients need, but don’t have—yet. To join our team or for more information, please visit www.verastem.com.

X/Twitter: @VerastemOncolog